Healthcare -
Biotechnology - NASDAQ - US
$ 35.06
-9.8 %
$ 3.29 B
Market Cap
-5.57
P/E
RARE - TOTAL RECEIVABLES
Total Receivables RARE - Ultragenyx Pharmaceutical Inc.
122 M
LAST VALUE
73.54%
2 YEAR CAGR
29.97%
5 YEAR CAGR
0.00%
10 YEAR CAGR